{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:20:19Z","timestamp":1793931619565,"version":"4.8.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T00:00:00Z","timestamp":1616371200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T00:00:00Z","timestamp":1616371200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000200","name":"USAID","doi-asserted-by":"crossref","award":["AID-617-A-17-00003"],"award-info":[{"award-number":["AID-617-A-17-00003"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The World Health Organization (WHO) End TB strategy aims to reduce mortality due to tuberculosis (TB) to less than 5% by 2035. However, mortality due to multidrug-resistant tuberculosis (MDR-TB) remains particularly high. Globally, almost 20% of patients started on MDR-TB treatment die during the course of treatment every year. We set out to examine the risk factors for mortality among a cohort of patients diagnosed with MDR-TB in Uganda.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a case-control study nested within the national MDR-TB cohort. We defined cases as patients who died from any cause during the course of MDR-TB treatment. We selected two controls for each case from patients alive and on MDR-TB treatment at the time that the death occurred (incidence-density sampling). We matched the cases and controls on health facility at which they were receiving care. We performed conditional logistic regression to identify the risk factors for mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Data from 198 patients (66 cases and 132 controls) started on MDR-TB treatment from January 1 to December 31, 2016, was analyzed for this study. Cases were similar to controls in age\/sex distribution, occupation and history of TB treatment. However, cases were more likely to be HIV infected while controls were more likely to have attained secondary level education. On multivariate regression analysis, co-infection with HIV (aOR 1.9, 95% CI [1.1\u20134.92]\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.05); non-adherence to MDR-TB treatment (aOR 1.92, 95% CI [1.02\u20134.83]\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04); age over 50\u2009years (aOR 3.04, 95% CI [1.13\u20138.20]\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.03); and having no education (aOR 3.61, 95% CI [1.1\u201310.4]\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.03) were associated with MDR-TB mortality.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>To mitigate MDR-TB mortality, attention must be paid to provision of social support particularly for older persons\u00a0on MDR-TB treatment. In addition, interventions that support treatment adherence and promote early detection and management of TB among HIV infected persons should also be emphasized.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-021-05967-2","type":"journal-article","created":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T10:04:13Z","timestamp":1616407453000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Risk factors for mortality among patients diagnosed with multi-drug resistant tuberculosis in Uganda- a case-control study"],"prefix":"10.1186","volume":"21","author":[{"given":"Enock","family":"Kizito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Musaazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Mutesasira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Twinomugisha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Namwanje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Kiyemba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora B.","family":"Freitas Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas Sebuliba","family":"Nicholas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abel","family":"Nkolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estella","family":"Birabwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyoum","family":"Dejene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8823-7082","authenticated-orcid":false,"given":"Stella","family":"Zawedde-Muyanja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,22]]},"reference":[{"key":"5967_CR1","unstructured":"World Health Organization. Definitions and reporting framework for tuberculosis - 2013 revision (updated Dec 2014 and Jan 2020). http:\/\/apps.who.int\/iris\/bitstream\/10665\/79199\/1\/9789241505345_eng.pdf."},{"key":"5967_CR2","volume-title":"Ministry of Health Uganda National Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis National Tuberculosis and Leprosy Program","author":"Ministry of Health U","year":"2016","unstructured":"Ministry of Health U. Ministry of Health Uganda National Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis National Tuberculosis and Leprosy Program. 2016."},{"key":"5967_CR3","volume-title":"Global Tuberculosis Report 2020","author":"WHO","year":"2020","unstructured":"WHO. Global Tuberculosis Report 2020. 2020."},{"key":"5967_CR4","volume-title":"The Republic of Uganda The Uganda National Tuberculosis Prevalence Survey, 2014-2015 Survey Report","author":"Uganda Ministry of Health","year":"2015","unstructured":"Uganda Ministry of Health. The Republic of Uganda The Uganda National Tuberculosis Prevalence Survey, 2014-2015 Survey Report 2015."},{"key":"5967_CR5","volume-title":"NTLP Annual Report","author":"Uganda Ministry of Health","year":"2019","unstructured":"Uganda Ministry of Health. NTLP Annual Report. 2019."},{"key":"5967_CR6","volume-title":"NTLP Annual Report","author":"Uganda MoH","year":"2019","unstructured":"Uganda MoH. NTLP Annual Report. 2019."},{"issue":"3","key":"5967_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1473-3099(09)70041-6","volume":"9","author":"EW Orenstein","year":"2009","unstructured":"Orenstein EW, Basu S, Shah NS, Andrews JR, Friedland GH, Moll AP, Gandhi NR, Galvani AP. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infect Dis. 2009;9(3):153\u201361. https:\/\/doi.org\/10.1016\/S1473-3099(09)70041-6.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"5967_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13756-019-0561-z","volume":"8","author":"IS Pradipta","year":"2019","unstructured":"Pradipta IS, Van\u2019T Boveneind-Vrubleuskaya N, Akkerman OW, Alffenaar JWC, Hak E. Treatment outcomes of drug-resistant tuberculosis in the Netherlands, 2005-2015. Antimicrob Resist Infect Control. 2019;8(1):1\u201312.","journal-title":"Antimicrob Resist Infect Control"},{"key":"5967_CR9","volume-title":"Compendium of indicators for monitoring and evaluating national tuberculosis programs. PoplineOrg","author":"L Adams","year":"2004","unstructured":"Adams L, Bergstrom K, Bleed D, Colvin C, Eckert E. Compendium of indicators for monitoring and evaluating national tuberculosis programs. PoplineOrg; 2004."},{"issue":"1","key":"5967_CR10","doi-asserted-by":"publisher","first-page":"90","DOI":"10.5588\/ijtld.11.0153","volume":"16","author":"NR Gandhi","year":"2012","unstructured":"Gandhi NR, Andrews JR, Brust JCM, Montreuil R, Weissman D, Heo M, Moll AP, Friedland GH, Shah NS. Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting. Int J Tuberc Lung Dis. 2012;16(1):90\u20137. https:\/\/doi.org\/10.5588\/ijtld.11.0153.","journal-title":"Int J Tuberc Lung Dis"},{"key":"5967_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0005361","volume":"4","author":"JC Johnston","year":"2009","unstructured":"Johnston JC, Shahidi NC, Sadatsafavi M, Fitzgerald JM. Treatment outcomes of multidrug-resistant tuberculosis: A systematic review and meta-analysis. PLoS One. 2009;4:1.","journal-title":"PLoS One"},{"issue":"3","key":"5967_CR12","doi-asserted-by":"publisher","first-page":"348","DOI":"10.5588\/ijtld.11.0473","volume":"16","author":"E Palacios","year":"2012","unstructured":"Palacios E, Franke M, Mu\u00f1oz M, Hurtado R, Dallman R, Chalco K, Guerra D, Mestanza L, LLaro K, Bonilla C, Sebastian J, Bayona J, Lygizos M, Anger H, Shin S. HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era. Int J Tuberc Lung Dis. 2012;16(3):348\u201354. https:\/\/doi.org\/10.5588\/ijtld.11.0473.","journal-title":"Int J Tuberc Lung Dis"},{"key":"5967_CR13","volume-title":"Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. Geneva: World Healh Organisation; 2017."},{"key":"5967_CR14","doi-asserted-by":"crossref","unstructured":"Kaplan R, Hermans S, Caldwell J, Jennings K, Bekker LG, Wood R. HIV and TB co-infection in the ART era: CD4 count distributions and TB case fatality in Cape Town. BMC Infect Dis. 2018;18(1).","DOI":"10.1186\/s12879-018-3256-9"},{"key":"5967_CR15","doi-asserted-by":"crossref","unstructured":"Yan S, Chen L, Wu W, FuZ, Zhang H, Li Z, FuC, Mou J, Xue J, Hu Y, Winston A. Early versus delayed antiretroviral therapy for HIV and tuberculosis co-infected patients: a systematic review and meta-analysis of randomized controlled trials. PLOS ONE. 2015;10(5):e0127645.","DOI":"10.1371\/journal.pone.0127645"},{"issue":"5","key":"5967_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0155968","volume":"11","author":"CD Mitnick","year":"2016","unstructured":"Mitnick CD, Rodriguez CA, Hatton ML, Brigden G, Cobelens F, Grobusch MP, et al. Programmatic Management of Drug-Resistant Tuberculosis: an updated research agenda. PLoS One. 2016;11(5):1\u201316.","journal-title":"PLoS One"},{"issue":"1","key":"5967_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40249-016-0214-x","volume":"6","author":"KT Kibret","year":"2017","unstructured":"Kibret KT, Moges Y, Memiah P, Biadgilign S. Treatment outcomes for multidrug-resistant tuberculosis under DOTS-plus: a systematic review and meta-analysis of published studies. Infect Dis Poverty. 2017;6(1):1\u20138.","journal-title":"Infect Dis Poverty"},{"key":"5967_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ijid.2014.11.018","volume":"32","author":"J Negin","year":"2015","unstructured":"Negin J, Abimbola S, Marais BJ. Tuberculosis among older adults - time to take notice. Int J Infect Dis. 2015;32:135\u20137. https:\/\/doi.org\/10.1016\/j.ijid.2014.11.018.","journal-title":"Int J Infect Dis"},{"issue":"10","key":"5967_CR19","doi-asserted-by":"publisher","first-page":"728","DOI":"10.7196\/SAMJ.2019.v109i10.14073","volume":"109","author":"M Loveday","year":"2019","unstructured":"Loveday M, Mzobe YN, Pillay Y, Barron P. Figures of the dead: a decade of tuberculosis mortality registrations in South Africa. S Afr Med J. 2019;109(10):728\u201332. https:\/\/doi.org\/10.7196\/SAMJ.2019.v109i10.14073.","journal-title":"S Afr Med J"},{"issue":"3","key":"5967_CR20","first-page":"805","volume":"2006","author":"DM Cutler","year":"2006","unstructured":"Cutler DM, Lleras-Muney A. Education and health: evaluating theories and evidence. Natl Bur Econ Res. 2006;2006(3):805\u201311.","journal-title":"Natl Bur Econ Res"},{"issue":"5","key":"5967_CR21","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2307\/2096319","volume":"60","author":"CE Ross","year":"2009","unstructured":"Ross CE, Wu C. The links between education and health. Am Sociol Rev. 2009;60(5):719\u201345.","journal-title":"Am Sociol Rev"},{"key":"5967_CR22","volume-title":"Uganda Demographic and Health Survey Key Indicators Report 2016. RoU.","author":"UDHS","year":"2017","unstructured":"UDHS. Uganda Demographic and Health Survey Key Indicators Report 2016. RoU. 2017."},{"issue":"1","key":"5967_CR23","first-page":"8","volume":"3","author":"J Wu","year":"2012","unstructured":"Wu J, Dalal K. Tuberculosis in Asia and the Pacific: the role of socioeconomic status and health system development. Int J Prev Med. 2012;3(1):8\u201316.","journal-title":"Int J Prev Med"},{"issue":"4","key":"5967_CR24","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1164\/ajrccm.157.4.9704036","volume":"157","author":"MF Cantwell","year":"1998","unstructured":"Cantwell MF, McKenna MT, McCray E, Onorato IM. Tuberculosis and race\/ethnicity in the United States: impact of socioeconomic status. Am J Respir Crit Care Med. 1998;157(4):1016\u201320. https:\/\/doi.org\/10.1164\/ajrccm.157.4.9704036.","journal-title":"Am J Respir Crit Care Med"},{"key":"5967_CR25","volume-title":"Direct and Indirect costs due to Tuberculosis and proportion of Tuberculosis-affected households experiencing catastrophic costs due to TB in Uganda","author":"Uganda Ministry of Health","year":"2019","unstructured":"Uganda Ministry of Health. Direct and Indirect costs due to Tuberculosis and proportion of Tuberculosis-affected households experiencing catastrophic costs due to TB in Uganda. 2019."},{"key":"5967_CR26","doi-asserted-by":"publisher","unstructured":"Walcott RL, Ingels JB, Corso PS, Zalwango S, Whalen CC, Sekandi JN. There\u2019s no such thing as a free TB diagnosis: catastrophic TB costs in urban Uganda. Glob Public Health. 2020;15(6):877\u201388. https:\/\/doi.org\/10.1080\/17441692.2020.1724313.","DOI":"10.1080\/17441692.2020.1724313"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-05967-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-021-05967-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-05967-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T10:06:39Z","timestamp":1616407599000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-05967-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,22]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["5967"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-05967-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-132293\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,22]]},"assertion":[{"value":"13 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study used routinely collected data extracted anonymously from patient charts and was granted a waiver from obtaining informed consent by the Joint Clinical Research Centre (JCRC-1419) Institutional Review Board (IRB), and by the Uganda National Council of Science and Technology (UNCST-2681). Administrative permission to access this data were provided by the National TB and Leprosy Program.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"292"}}